Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dow Inc. stock logo
DOW
DOW
$38.75
-0.1%
$38.19
$20.40
$42.74
$27.96B0.4713.81 million shs5.16 million shs
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$18.82
-0.8%
$21.86
$18.28
$31.41
$479.17M1.04400,158 shs358,190 shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$129.53
-1.9%
$138.14
$100.23
$157.29
$160.68B0.316.74 million shs3.80 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dow Inc. stock logo
DOW
DOW
-0.20%+4.20%-0.98%+19.36%+28.67%
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
+1.36%-7.16%-15.62%-20.46%-29.78%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
-0.74%-1.49%-5.97%-14.79%+34.23%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dow Inc. stock logo
DOW
DOW
$38.75
-0.1%
$38.19
$20.40
$42.74
$27.96B0.4713.81 million shs5.16 million shs
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$18.82
-0.8%
$21.86
$18.28
$31.41
$479.17M1.04400,158 shs358,190 shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$129.53
-1.9%
$138.14
$100.23
$157.29
$160.68B0.316.74 million shs3.80 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dow Inc. stock logo
DOW
DOW
-0.20%+4.20%-0.98%+19.36%+28.67%
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
+1.36%-7.16%-15.62%-20.46%-29.78%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
-0.74%-1.49%-5.97%-14.79%+34.23%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dow Inc. stock logo
DOW
DOW
2.55
Moderate Buy$41.336.68% Upside
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
1.67
Reduce$24.0027.50% Upside
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.86
Moderate Buy$157.0421.24% Upside

Current Analyst Ratings Breakdown

Latest GILD, DOW, and ETD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2026
Dow Inc. stock logo
DOW
DOW
Boost Price Target$33.00 ➝ $35.00
5/13/2026
Dow Inc. stock logo
DOW
DOW
UpgradeHoldBuy
5/11/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
UpgradeBuy (B-)Buy (B)
5/11/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Lower Price Target$170.00 ➝ $167.00
5/8/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Lower Price Target$175.00 ➝ $168.00
5/8/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Lower Price Target$148.00 ➝ $146.00
5/8/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Reiterated RatingBuy$155.00 ➝ $157.00
5/8/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Lower Price TargetSector Perform$123.00 ➝ $122.00
5/4/2026
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
DowngradeHold (C-)Sell (D+)
4/30/2026
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
Lower Price TargetMarket Perform$27.00 ➝ $24.00
4/28/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Boost Price TargetOverweight$171.00 ➝ $175.00
(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dow Inc. stock logo
DOW
DOW
$39.97B0.70$3.03 per share12.80$23.26 per share1.67
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$593.09M0.81$2.69 per share7.01$18.62 per share1.01
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$29.44B5.46$10.19 per share12.71$18.87 per share6.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dow Inc. stock logo
DOW
DOW
-$2.62B-$3.99N/A22.530.29-7.24%-4.29%-1.29%7/23/2026 (Estimated)
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$51.60M$1.5811.9211.77N/A6.81%8.54%5.60%7/29/2026 (Estimated)
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$8.51B$7.3417.6313.35N/A30.99%48.19%18.28%N/A

Latest GILD, DOW, and ETD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$1.91$2.03+$0.12$1.61$6.91 billion$6.96 billion
4/29/2026Q3 2026
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$0.21$0.24+$0.03$0.23$134.85 million$135.84 million
4/23/2026Q1 2026
Dow Inc. stock logo
DOW
DOW
-$0.2903-$0.14+$0.1503-$0.74$9.57 billion$9.79 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Dow Inc. stock logo
DOW
DOW
$1.403.61%-5.59%N/A N/A
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$1.568.29%+19.04%98.73%1 Years
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$3.282.53%+3.04%44.69%10 Years

Latest GILD, DOW, and ETD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/29/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
quarterly$0.822.45%6/15/20266/15/20266/29/2026
4/9/2026
Dow Inc. stock logo
DOW
DOW
quarterly$0.353.68%5/29/20265/29/20266/12/2026
4/28/2026
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
quarterly$0.398.34%5/13/20265/13/20265/27/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dow Inc. stock logo
DOW
DOW
1.03
1.85
1.20
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
N/A
1.94
0.94
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.89
1.97
1.77

Institutional Ownership

CompanyInstitutional Ownership
Dow Inc. stock logo
DOW
DOW
64.00%
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
83.80%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
83.67%

Insider Ownership

CompanyInsider Ownership
Dow Inc. stock logo
DOW
DOW
0.50%
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
9.92%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Dow Inc. stock logo
DOW
DOW
34,600720.74 million717.14 millionOptionable
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
3,21125.45 million22.92 millionOptionable
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
17,0001.24 billion1.24 billionOptionable

Recent News About These Companies

Oppenheimer Remains a Buy on Gilead Sciences (GILD)
Gilead Sciences, Inc. $GILD Shares Sold by Conning Inc.
Gilead Prices $3 Billion of Senior Unsecured Notes
Gilead Prices $3 Billion of Senior Unsecured Notes
Gilead's Transition Into A Long-Duration Biotech Platform

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
DOW stock logo

DOW NYSE:DOW

$38.74 -0.04 (-0.09%)
As of 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Dow, Inc. is a materials science company, which engages in the development of innovative solutions. It operates through the following segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment consists of hydrocarbons and energy and packaging and specialty plastics. The Industrial Intermediates and Infrastructure segment covers the industrial solutions and polyurethanes and construction chemicals. The Performance Materials and Coatings segment includes coatings and performance monomers and consumer solutions. The company was founded in 1897 and is headquartered in Midland, MI.

Ethan Allen Interiors stock logo

Ethan Allen Interiors NYSE:ETD

$18.82 -0.16 (-0.82%)
As of 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Ethan Allen Interiors Inc. operates as an interior design company, and manufacturer and retailer of home furnishings in the United States, Mexico, Honduras, and Canada. The company operates in two segments, Wholesale and Retail. Its products include case goods items, such as beds, dressers, armoires, tables, chairs, buffets, entertainment units, home office furniture, and wooden accents; upholstery comprising fabric-covered items, such as sleepers, recliners and other motion furniture, chairs, ottomans, custom pillows, sofas, loveseats, cut fabrics, and leather; and home accent items consisting of window treatments and drapery hardware, wall decors, florals, lighting, clocks, mattresses, bedspreads, throws, pillows, decorative accents, area rugs, wall coverings, and home and garden furnishings. The company markets and sells its products under the Ethan Allen brand through home furnishing retail networks and independent retailers, as well as through ethanallen.com website. It operates a network of design centers. Ethan Allen Interiors Inc. was founded in 1932 and is headquartered in Danbury, Connecticut.

Gilead Sciences stock logo

Gilead Sciences NASDAQ:GILD

$129.53 -2.53 (-1.92%)
As of 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.